Arrhythmia Research Technology (HRT) Swings to Q4 Profit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Arrhythmia Research Technology Reports 12.8% Net Sales Growth and 5.1 Point Margin Expansion in 2014
March 20, 2015 6:55 AM EDTNet sales grew 12.8% to $24.1 million in 2014 Full year gross margin expanded 5.1 points to 19.3%, driven by improved efficiencies and higher volumes Achieved net income of $0.7 million, or $0.23 per diluted share, in 2014 Generated $1.8 million of cash from operations for the year Adjusted EBITDA(1), a non-GAAP measure, grew $1.9 million to $2.5 million in 2014
FITCHBURG, Mass., March 20, 2015 (GLOBE NEWSWIRE) -- Arrhythmia Research Technology, Inc. (NYSE MKT: HRT) (the "Company"), through its wholly-owned subsidiary, Micron Products, Inc., is a diversified contract... More
